| Transtracheal oxygen therapy: an effective and safe alternative to nasal oxygen administration. | |
| | |
MedLine Citation:
|
PMID: 9150320 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Transtracheal oxygen therapy (TTOT) improves the efficiency of oxygen delivery and overcomes the discomfort associated with nasal oxygen delivery in patients on long-term oxygen therapy (LTOT). In addition, TTOT improves compliance and quality of life, and may reduce morbidity. Experience with TTOT in Europe is, however, scarce and the safety of TTOT has not yet been completely determined. These were reasons for testing the acceptance, efficacy and safety of TTOT. Patients were selected on the basis of the accepted indications and contraindications for TTOT. In 75 patients (48 males and 27 females) the mean follow-up time was 16 (range 0.5-51.5) months. Compared to nasal cannulae, TTOT caused a reduction in the oxygen flow rate of 47 (33-60)% at rest and a significant increase in the number of hours that oxygen was used. All patients on TTOT used oxygen for at least 20 h x day(-1). Most patients saw the procedure as a minor intervention. It was usually performed on an out-patient basis. In 34 patients, 51 mainly minor complications were seen, and most of these occurred in the first 10 patients. After precautions had been taken, complications occurred less frequently. No patient needed to be hospitalized because of a complication. TTOT had to be stopped in two patients; nevertheless, all patients preferred TTOT to the nasal cannulae. We conclude that transtracheal oxygen therapy is an effective and safe alternative to nasal oxygen administration, provided that it is restricted to a well-defined group of patients and applied by a motivated and experienced group of physicians. |
| | |
Authors:
|
M J Kampelmacher; M Deenstra; R G van Kesteren; C F Melissant; J M Douze; J W Lammers |
Publication Detail:
|
Type: Clinical Trial; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology Volume: 10 ISSN: 0903-1936 ISO Abbreviation: Eur. Respir. J. Publication Date: 1997 Apr |
Date Detail:
|
Created Date: 1997-07-29 Completed Date: 1997-07-29 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 8803460 Medline TA: Eur Respir J Country: DENMARK |
Other Details:
|
Languages: eng Pagination: 828-33 Citation Subset: IM |
Affiliation:
|
Centre for Home Mechanical Ventilation, Division of Internal Medicine and Dermatology, University Hospital Utrecht, The Netherlands. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Administration, Intranasal Adult Aged Analysis of Variance Female Humans Intubation, Intratracheal Lung Diseases / mortality, physiopathology, therapy Male Middle Aged Oxygen Inhalation Therapy / adverse effects, methods* Respiratory Insufficiency / etiology, mortality, therapy* Survival Rate Treatment Outcome |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Gender difference in smoking effects on lung function and risk of hospitalization for COPD: results ...
Next Document: Effect of corticosteroids on release of RANTES and sICAM-1 from cultured human bronchial epithelial ...